118 related articles for article (PubMed ID: 7931839)
1. Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation.
Penault-Llorca F; Adelaïde J; Houvenaeghel G; Hassoun J; Birnbaum D; Jacquemier J
J Pathol; 1994 May; 173(1):65-75. PubMed ID: 7931839
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.
Pauletti G; Godolphin W; Press MF; Slamon DJ
Oncogene; 1996 Jul; 13(1):63-72. PubMed ID: 8700555
[TBL] [Abstract][Full Text] [Related]
3. Comparative multi-methodological measurement of ERBB2 status in breast cancer.
Ginestier C; Charafe-Jauffret E; Penault-Llorca F; Geneix J; Adélaïde J; Chaffanet M; Mozziconacci MJ; Hassoun J; Viens P; Birnbaum D; Jacquemier J
J Pathol; 2004 Mar; 202(3):286-98. PubMed ID: 14991893
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
Press MF; Hung G; Godolphin W; Slamon DJ
Cancer Res; 1994 May; 54(10):2771-7. PubMed ID: 7909495
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
el-A Helal T; Khalifa A; Kamel AS
Anticancer Res; 2000; 20(3B):2145-50. PubMed ID: 10928168
[TBL] [Abstract][Full Text] [Related]
6. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.
Rhodes A; Jasani B; Anderson E; Dodson AR; Balaton AJ
Am J Clin Pathol; 2002 Sep; 118(3):408-17. PubMed ID: 12219783
[TBL] [Abstract][Full Text] [Related]
9. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer.
Rhodes A; Jasani B; Couturier J; McKinley MJ; Morgan JM; Dodson AR; Navabi H; Miller KD; Balaton AJ
Am J Clin Pathol; 2002 Jan; 117(1):81-9. PubMed ID: 11789735
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases.
Gancberg D; Lespagnard L; Rouas G; Paesmans M; Piccart M; Di Leo A; Nogaret JM; Hertens D; Verhest A; Larsimont D
Am J Clin Pathol; 2000 May; 113(5):675-82. PubMed ID: 10800400
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer.
Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Sugano K; Ohkura H
J Med Assoc Thai; 1996 Nov; 79(11):715-21. PubMed ID: 8997010
[TBL] [Abstract][Full Text] [Related]
12. Comparison of formalin, ethanol, and Histochoice fixation on the PCR amplification from paraffin-embedded breast cancer tissue.
Giannella C; Zito FA; Colonna F; Paradiso A; Marzullo F; Alaibac M; Schittulli F
Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):633-5. PubMed ID: 9298355
[TBL] [Abstract][Full Text] [Related]
13. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
[TBL] [Abstract][Full Text] [Related]
14. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
Erdogan S; Ergin M; Tuncer I
Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of VHS virus in paraffin-embedded specimens of rainbow trout (Oncorhynchus mykiss): the influence of primary antibody, fixative, and antigen unmasking on method sensitivity.
Evensen O; Olesen NJ
Vet Pathol; 1997 May; 34(3):253-61. PubMed ID: 9163887
[TBL] [Abstract][Full Text] [Related]
16. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma.
Couturier J; Vincent-Salomon A; Nicolas A; Beuzeboc P; Mouret E; Zafrani B; Sastre-Garau X
Mod Pathol; 2000 Nov; 13(11):1238-43. PubMed ID: 11106082
[TBL] [Abstract][Full Text] [Related]
17. Fixation time does not affect expression of HER2/neu: a pilot study.
Ibarra JA; Rogers LW
Am J Clin Pathol; 2010 Oct; 134(4):594-6. PubMed ID: 20855640
[TBL] [Abstract][Full Text] [Related]
18. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
20. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]